AIDS Treatment News logo      

July 23, 2009

Boosted darunavir monotherapy works well in two studies

"Ritonavir-boosted darunavir (Prezista) alone maintains HIV suppression in most patients who achieved an undetectable viral load on combination antiretroviral therapy, according to two studies presented this week at the Fifth International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention in Cape Town, South Africa."

Read more in Aidsmap, July23, 2009.